Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Enfermedad de Alzheimer y Demencias

1359 ARTÍCULOS , VIENDO DEL 541 AL 555

Do treatment effects vary among differing baseline depression criteria in depression in Alzheimer's disease study ± 2 (DIADS-2)?

Drye LT, Martin BK, Frangakis CE, Meinert CL, Mintzer JE, Munro CA, Porsteinsson AP, Rabins PV, Rosenberg PB, Schneider LS, Weintraub D, Lyketsos CG; DIADS-2 Research Group.

Int J Geriatr Psychiatry. 2011 Jun;26(6):573-83. doi: 10.1002/gps.2565.

Primary cerebral blood flow deficiency and Alzheimer's disease: shadows and lights

Mazza M, Marano G, Traversi G, Bria P, Mazza S.

J Alzheimers Dis. 2011;23(3):375-89. doi: 10.3233/JAD-2010-090700.

Long-term effects of galantamine treatment on brain functional activities as measured by PET in Alzheimer's disease patients

Keller C, Kadir A, Forsberg A, Porras O, Nordberg A.

J Alzheimers Dis. 2011;24(1):109-23. doi: 10.3233/JAD-2010-101290.

Usefulness of 18F-fluorodeoxyglucose positron emission tomography for diagnosis of asymptomatic giant cell arteritis in a patient with Alzheimer's disease

Kushida S, Akisaki T, Yasuda H, Moriyama H, Hara K, Nagata M, Taniguchi M, Urakami K, Yokono K, Sakurai T.

Geriatr Gerontol Int. 2011 Jan;11(1):114-8. doi: 10.1111/j.1447-0594.2010.00663.x.

Galantamine (Reminyl) once daily outcome and satisfaction survey (RODOS) in mild to moderate Alzheimer's disease: a study in a real life population

Van Puyvelde K, Mets T; RODOS Study Group.

Geriatr Gerontol Int. 2011 Jul;11(3):256-61. doi: 10.1111/j.1447-0594.2010.00674.x. Epub 2011 Jan 4.

EEG and granular osmiophilic elements in early-onset Alzheimer's disease

Alberici A, Borroni B, Bonato C, Agosti C, Avanzi S, Santorelli FM, Simonati A, Padovani A.

Neurodegener Dis. 2011;8(4):259-61. doi: 10.1159/000322539. Epub 2011 Jan 7.

Treatment with cholinesterase inhibitors and memantine of patients in the Alzheimer's Disease Neuroimaging Initiative

Schneider LS, Insel PS, Weiner MW; Alzheimer's Disease Neuroimaging Initiative.

Arch Neurol. 2011 Jan;68(1):58-66. doi: 10.1001/archneurol.2010.343.

Alzheimer's disease and intelligence

Yeo RA, Arden R, Jung RE.

Curr Alzheimer Res. 2011 Jun;8(4):345-53. doi: 10.2174/156720511795745276.

In vivo human amyloid imaging

Sojkova J, Resnick SM.

Curr Alzheimer Res. 2011 Jun;8(4):366-72. doi: 10.2174/156720511795745375.

Remembering relationships: preserved emotion-based learning in Alzheimer's disease

Evans-Roberts CE, Turnbull OH.

Exp Aging Res. 2011 Jan;37(1):1-16. doi: 10.1080/0361073X.2011.536750.

Nonliteral language in Alzheimer dementia: a review

Rapp AM, Wild B.

J Int Neuropsychol Soc. 2011 Mar;17(2):207-18. doi: 10.1017/S1355617710001682. Epub 2011 Jan 18.

Alzheimer's disease: future treatments

Morley JE.

J Am Med Dir Assoc. 2011 Jan;12(1):1-7. doi: 10.1016/j.jamda.2010.10.008.

Effect of memantine on resting state default mode network activity in Alzheimer's disease

Lorenzi M, Beltramello A, Mercuri NB, Canu E, Zoccatelli G, Pizzini FB, Alessandrini F, Cotelli M, Rosini S, Costardi D, Caltagirone C, Frisoni GB.

Drugs Aging. 2011 Mar 1;28(3):205-17. doi: 10.2165/11586440-000000000-00000.

Operationalizing diagnostic criteria for Alzheimer's disease and other age-related cognitive impairment-Part 2

Seshadri S, Beiser A, Au R, Wolf PA, Evans DA, Wilson RS, Petersen RC, Knopman DS, Rocca WA, Kawas CH, Corrada MM, Plassman BL, Langa KM, Chui HC.

Alzheimers Dement. 2011 Jan;7(1):35-52. doi: 10.1016/j.jalz.2010.12.002.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias